X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84) 84
female (53) 53
hiv-1 - genetics (53) 53
index medicus (49) 49
infectious diseases (48) 48
male (48) 48
virology (45) 45
hiv infections - virology (41) 41
hiv (38) 38
spain (37) 37
adult (35) 35
hiv-1 - classification (34) 34
hiv infections - epidemiology (32) 32
hiv-1 (29) 29
spain - epidemiology (28) 28
drug resistance (27) 27
mutation (27) 27
phylogeny (27) 27
microbiology (26) 26
non-b subtypes (25) 25
prevalence (25) 25
immunology (24) 24
molecular sequence data (24) 24
epidemiology (22) 22
hiv infections - drug therapy (22) 22
middle aged (22) 22
viral load (22) 22
hiv-1 - drug effects (20) 20
genetic diversity (19) 19
hiv-1 - isolation & purification (19) 19
human immunodeficiency virus--hiv (19) 19
subtypes (19) 19
antiretroviral therapy (18) 18
infection (18) 18
mutations (18) 18
immunodeficiency-virus type-1 (17) 17
aids (15) 15
human immunodeficiency virus (15) 15
medicine (15) 15
adolescent (14) 14
anti-hiv agents - therapeutic use (14) 14
antiretroviral drugs (14) 14
genetic variation (14) 14
research article (14) 14
sequence analysis, dna (14) 14
children (13) 13
drug resistance, viral (13) 13
drug resistance, viral - genetics (13) 13
genotype (13) 13
hiv infections - diagnosis (13) 13
human-immunodeficiency-virus (13) 13
protease inhibitors (13) 13
reverse-transcriptase (13) 13
hiv infection (12) 12
molecular epidemiology (12) 12
virus diseases (12) 12
acquired immune deficiency syndrome (11) 11
acquired immune deficiency syndrome--aids (11) 11
child (11) 11
hiv infections - transmission (11) 11
identification (11) 11
multidisciplinary sciences (11) 11
pediatrics (11) 11
science (11) 11
transmission (11) 11
analysis (10) 10
diagnosis (10) 10
drug therapy (10) 10
drug-resistance (10) 10
hiv protease - genetics (10) 10
infant (10) 10
infectious disease (10) 10
recombinants (10) 10
young adult (10) 10
africa (9) 9
anti-hiv agents - pharmacology (9) 9
antiviral agents (9) 9
emigration and immigration (9) 9
health aspects (9) 9
pharmacology & pharmacy (9) 9
pol gene products, human immunodeficiency virus - genetics (9) 9
polymorphism, genetic (9) 9
protease (9) 9
recombination, genetic (9) 9
type-1 (9) 9
amino acid sequence (8) 8
diversity (8) 8
dried blood spots (8) 8
ltr (8) 8
research (8) 8
sensitivity and specificity (8) 8
antiretroviral agents (7) 7
base sequence (7) 7
cohort studies (7) 7
disease progression (7) 7
hiv infections - genetics (7) 7
hiv-1 subtypes (7) 7
infections (7) 7
plasma (7) 7
proteases (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rhee, Soo-Yon and Blanco, Jose Luis and Jordan, Michael R and Taylor, Jonathan and Lemey, Philippe and Varghese, Vici and Hamers, Raph L and Bertagnolio, Silvia and Rinke de Wit, Tobias F and Aghokeng, Avelin F and Albert, Jan and Avi, Radko and Avila-Rios, Santiago and Bessong, Pascal O and Brooks, James I and Boucher, Charles A. B and Brumme, Zabrina L and Busch, Michael P and Bussmann, Hermann and Chaix, Marie-Laure and Chin, Bum Sik and D'Aquin, Toni T and de Gascun, Cillian F and Derache, Anne and Descamps, Diane and Deshpande, Alaka K and Djoko, Cyrille F and Eshleman, Susan H and Fleury, Herve and Frange, Pierre and Fujisaki, Seiichiro and Harrigan, P. Richard and Hattori, Junko and Holguin, Africa and Hunt, Gillian M and Ichimura, Hiroshi and Kaleebu, Pontiano and Katzenstein, David and Kiertiburanakul, Sasisopin and Kim, Jerome H and Kim, Sung Soon and Li, Yanpeng and Lutsar, Irja and Morris, Lynn and Ndembi, Nicaise and Ng, Kee Peng and Paranjape, Ramesh S and Peeters, Martine and Poljak, Mario and Price, Matt A and Ragonnet-Cronin, Manon L and Reyes-Terán, Gustavo and Rolland, Morgane and Sirivichayakul, Sunee and Smith, Davey M and Soares, Marcelo A and Soriano, Vincent V and Ssemwanga, Deogratius and Stanojevic, Maja and Stefani, Mariane A and Sugiura, Wataru and Sungkanuparph, Somnuek and Tanuri, Amilcar and tee, Kok Keng and Truong, Hong-Ha M and van de Vijver, David A. M. C and Vidal, Nicole and Yang, Chunfu and Yang, Rongge and Yebra, Gonzalo and Ioannidis, John P. A and Vandamme, Anne-Mieke and Shafer, Robert W
PLoS medicine, ISSN 1549-1277, 2015, Volume 12, Issue 4, p. e1001810
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0167383
Understanding the factors that modulate the evolution of virus populations is essential to design efficient control strategies. Mathematical models predict... 
GENETIC DIVERSITY | POPULATION | RATES | PERINATAL TRANSMISSION | VIRUS | MOTHER-TO-CHILD | MULTIDISCIPLINARY SCIENCES | NON-B SUBTYPES | WITHIN-HOST | INFECTED INFANTS | DISEASE PROGRESSION | HIV-1 - pathogenicity | HIV Infections - genetics | HIV Infections - virology | Humans | Child, Preschool | Infant | Male | Anti-HIV Agents | HIV-1 - genetics | Viral Load | Spain | Antiretroviral Therapy, Highly Active | Biological Evolution | Genetic Variation | Drug Resistance, Viral - genetics | Host-Pathogen Interactions - genetics | Adult | Female | HIV Infections - drug therapy | CD4-Positive T-Lymphocytes | Mutation | Child | Infant, Newborn | Antiviral agents | Analysis | Genetic aspects | Dosage and administration | Research | Host-virus relationships | HIV (Viruses) | Drug resistance | Drug therapy | HIV infection | Risk factors | Pediatrics | Populations | Disease | Laboratories | Biological evolution | Viruses | Infections | Epidemiology | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Population | Evolution | Mathematical models | Children | Bioinformatics | Age | Antiretroviral drugs | Sequences | Principal components analysis | Genetic diversity | Gene expression | Patients | CD4 antigen | Adults | Evolution & development | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0165333
Journal Article
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 02/2016, Volume 71, Issue 2, p. 362
  We evaluated variant-associated variability at positions related to resistance to the integrase (IN) inhibitors (INIs) raltegravir, elvitegravir and... 
Antiretroviral drugs | Human immunodeficiency virus--HIV | Amino acids | Drug resistance
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 12/2008, Volume 46, Issue 12, pp. 3896 - 3899
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173168
Background The most-used protease-inhibitor in children is Lopinavir-ritonavir (LPV/r), which provides durable suppression of viral load and increases... 
VIROLOGICAL SUCCESS | 1ST-LINE ANTIRETROVIRAL THERAPY | MULTIDISCIPLINARY SCIENCES | PROTEASE-INHIBITOR | LABEL | LOPINAVIR/RITONAVIR | DRUG-RESISTANCE | MUTATIONS | NEVIRAPINE | HIV-INFECTED CHILDREN | PEDIATRIC POPULATION | HIV Infections - epidemiology | Humans | Child, Preschool | Infant | Male | Host-Pathogen Interactions - drug effects | CD4-CD8 Ratio | HIV-1 - physiology | Ritonavir - therapeutic use | Female | Child | Infant, Newborn | HIV-1 - drug effects | HIV Infections - virology | Treatment Outcome | CD4 Lymphocyte Count | HIV-1 - genetics | HIV Protease Inhibitors - therapeutic use | Drug Resistance, Viral - genetics | Viremia - virology | Spain - epidemiology | Adolescent | HIV Infections - drug therapy | Lopinavir - therapeutic use | Mutation | Viral Load - drug effects | Drug Combinations | Cohort Studies | Care and treatment | Prognosis | Ritonavir | Lopinavir | Dosage and administration | Research | Drug therapy, Combination | HIV infection | Health aspects | Therapy | CD8 antigen | Proteinase | Parents | Infants | Drug resistance | Epidemiology | Incidence | Highly active antiretroviral therapy | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Classification | Diagnosis | Antiretroviral drugs | Committees | Exposure | Amplification | Side effects | Infectious diseases | Inhibitors | Predictions | Adults | Protocol (computers) | Drugs | Adolescence | Sexually transmitted diseases--STD | Microbiology | Grain | Prophylaxis | Medical services | Clinical trials | Population studies | Viruses | Lymphocytes T | Ethics | Immunology | Antiretroviral agents | Children | Adolescents | Age | Enzyme-linked immunosorbent assay | Antiviral agents | Lamivudine | Ribonucleic acid--RNA | Adhesion | Morbidity | CD4 antigen | Protease inhibitors | DRM protein | RNA | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus | Ribonucleic acid | HIV | Sexually-transmitted diseases
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2011, Volume 6, Issue 10, p. e26757
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 04/2019, Volume 9, Issue 1, pp. 5679 - 11
Point-of-Care (POC) molecular assays improve HIV infant diagnosis and viral load (VL) quantification in resource-limited settings. We evaluated POC performance... 
VIRAL LOAD | GENETIC DIVERSITY | AMPLIPREP/COBAS TAQMAN HIV-1 | EARLY INFANT DIAGNOSIS | SCALE-UP | VIRUS | TYPE-1 GROUP-M | MULTIDISCIPLINARY SCIENCES | ASSAYS | INFECTION | ANTIRETROVIRAL TREATMENT | Recombinants | Children | Diagnosis | Viremia | Human immunodeficiency virus--HIV
Journal Article
Medicina Clinica, ISSN 0025-7753, 10/2010, Volume 135, Issue 12, pp. 561 - 567
HIV-1 drug-resistance transmission compromises the effectiveness of antiretroviral therapy. Thus, epidemiological studies of resistance in nave patients... 
HIV-1 | Prevalence | Transmission | Nave patients | Primary resistance mutations | Spain
Journal Article
Enfermedades Infecciosas y Microbiologia Clinica, ISSN 0213-005X, 02/2013, Volume 31, Issue 2, pp. 100 - 107
As access to antiretroviral treatment increases in the developing countries, efforts towards making it easier and less costly to collect, store, and deliver... 
Developing countries | Dried blood spots (DBS) | Diagnosis | Sub-types | Viral load | Monitoring | Human immunodeficiency virus (HIV)
Journal Article
Medicina Clínica, ISSN 0025-7753, 2009, Volume 135, Issue 12, pp. 561 - 567
Resumen La transmisión de variantes resistentes del virus de la inmunodeficiencia humana de tipo 1 (VIH-1) pone en peligro la eficacia del tratamiento... 
Internal Medicine | HIV-1 | Prevalence | Prevalencia | Transmission | España | Virus de la inmunodeficiencia humana de tipo 1 | Primary resistance mutations | Mutaciones de resistencia primaria | Transmisión | Naïve patients | Pacientes naive | Spain
Journal Article